FDA green-lights powerful new flu vaccine in world-first
FDA green-lights powerful new flu vaccine in world-first
FDA green-lights powerful new flu vaccine in world-first
Clinical trials showed it is 27% more effective than conventional flu shots, which have used the same basic technology for over 70 years. The mRNA approach also cuts manufacturing time from 6 months to 2 to 3 months, allowing faster responses to an infectious disease that kills up to 52,000 Americans annually.